Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00874094

Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds

Sponsor: The New York Eye & Ear Infirmary

Interventions Platelet rich fibrin matrix

Updated 7 times since 2017 Last updated: Jul 10, 2013 Started: Apr 30, 2008 Primary completion: Jun 30, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00874094, this PHASE1/PHASE2 trial focuses on Nasolabial Folds and remains completed. Sponsored by The New York Eye & Ear Infirmary, it has been updated 7 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The New York Eye & Ear Infirmary

Data source: The New York Eye & Ear Infirmary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chappaqua, United States